AIMEDIC 로고 이미지
모바일 메뉴 닫기
About AIMEDIC
모바일 서브 메뉴 닫기
Our Story
Our History
Products
모바일 서브 메뉴 닫기
HeartMedi+
AutoSeg
AngioFFR
CardioLucid
Publications
모바일 서브 메뉴 닫기
News
모바일 서브 메뉴 닫기
Contact us
모바일 서브 메뉴 닫기
Back to Publications

AIMEDIC Publications

Forskolin increases angiogenesis through the coordinated cross-talk of PKA-dependent VEGF expression and Epac-mediated PI3K/Akt/eNOS signaling

Category
Pub
Date
2009-06-01
Source
Cellular signalling

Forskolin, a potent activator of adenylyl cyclases, has been implicated in modulating angiogenesis, but the underlying mechanism has not been clearly elucidated. We investigated the signal mechanism by which forskolin regulates angiogenesis. Forskolin stimulated angiogenesis of human endothelial cells and in vivo neovascularization, which was accompanied by phosphorylation of CREB, ERK, Akt, and endothelial nitric oxide synthase (eNOS) as well as NO production and VEGF expression. Forskolin-induced CREB phosphorylation, VEGF promoter activity, and VEGF expression were blocked by the PKA inhibitor PKI. Moreover, phosphorylation of ERK by forskolin was inhibited by the MEK inhibitor PD98059, but not PKI. The forskolin-induced Akt/eNOS/NO pathway was completely inhibited by the phosphatidylinositol 3-kinase (PI3K) inhibitor LY294002, but not significantly suppressed by PKI. These inhibitors …

Content update: API publication dates are used first. Review the abstract, source link, product intended use, and limitations together.

맨 위로 이동